UNSPSC 51162102: Isoniazid/pyridoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM500. This VA Drug Class (AM500) classifies this compound as belonging to the group ANTITUBERCULARS.

UNSPSC 51162102 Isoniazid/pyridoxine is a Commodity code that captures pharmaceutical procurement by state and local governments, though recent opportunities solicited under this code show substantial scope divergence — the posted activity actually encompasses naloxone, pharmacy services contracting, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals rather than the specific tuberculosis-treatment combination named in the code. State and local issuing bodies soliciting pharmaceutical products and services include county health departments, county government employee health plans, state health and human services agencies, and cooperative purchasing alliances serving multiple states. Seminole County, Florida (IFB 60459723LAS, posted June 30, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford. Hall County, Georgia (RFQ/P #47-010, posted May 4, 2026) issued a Request for Qualifications with Cost Proposal to procure on-site pharmacy services at the Hall County Government Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible individuals across multiple insurance plans, with responses due June 4, 2026.

Geographic activity spans multiple states, with recent solicitations in Florida, Georgia, Texas, and Minnesota. The Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) sought vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to establish direct relationships between the state pharmacy benefit program and pharmaceutical manufacturers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, posted January 20, 2026) serving participating state and local government facilities including Oregon, with proposals due March 26, 2026; the contract will be effective July 1, 2026, and vendors must maintain relationships with authorized wholesalers AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Recent opportunities indicate significant activity in cooperative purchasing and pharmacy benefit program administration, though the code's nominal scope does not align clearly with the actual work being procured.